A Clinical Trial of Esophagectomy for Esophageal Carcinoma
NCT ID: NCT06691503
Last Updated: 2024-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
35 participants
INTERVENTIONAL
2021-03-01
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thirty-five eligible patients with ESCC were assigned to the MATLE group, while seventy matched patients were assigned to the VATE group. The study compared perioperative outcomes and lymph node dissection between the two groups. Additionally, the Kaplan-Meier method was employed to estimate Disease-Free Survival (DFS) and Overall Survival (OS).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer
NCT04125849
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy
NCT05105945
Role of Esophagectomy in Complete Responders to CCRT
NCT01740375
Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT02355249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* histologically confirmed
* potentially resectable thoracic ESCC clinically staged as T1b-3N0M0 or Tis-1aN0M0 who was not suitable for endoscopic resection according to the 8th edition of the American Joint Committee on Cancer staging system and National Comprehensive Cancer Network Clinical Practice Guidelines in Esophageal and Esophagogastric Junction Cancers
* age 18-70 years,
* normal hematologic and organ function -Karnofsky Performance Scale (KPS) was assessed as 100 or 90
Exclusion Criteria
* severe comorbidities
* active autoimmune disease
* prior non-infectious pneumonitis or interstitial lung disease
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weijie Ye
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
651 Dongfeng Road East, Yuexiu District, Guangzhou, P.R. China
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SL-5010-2019-03-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.